Dermapharm Holding SE (DMPHF)
48.60
0.00 (0.00%)
USD |
OTCM |
May 08, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 2.617B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 26.12% |
| Valuation | |
| PE Ratio | 17.45 |
| PE Ratio (Forward) | |
| PS Ratio | 1.989 |
| Price to Book Value | 3.209 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 1.038 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 1.515 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The company operates through the Branded pharmaceuticals and other healthcare products, Parallel import business and Herbal extracts divisions. Its products include covers prescription pharmaceuticals (Rx), over-the-counter (OTC) products, medical devices, food supplements and cosmetics. The company was founded in 1991 and is headquartered in Grunwald, Germany. |
| URL | http://www.dermapharm.de |
| Investor Relations URL | N/A |
| HQ State/Province | Bayern (Bavaria) |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | May. 13, 2026 |
| Last Earnings Release | Nov. 13, 2025 |
| Next Ex-Dividend Date | Jun. 30, 2026 |
| Last Ex-Dividend Date | Jun. 27, 2025 |
Profile
| Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The company operates through the Branded pharmaceuticals and other healthcare products, Parallel import business and Herbal extracts divisions. Its products include covers prescription pharmaceuticals (Rx), over-the-counter (OTC) products, medical devices, food supplements and cosmetics. The company was founded in 1991 and is headquartered in Grunwald, Germany. |
| URL | http://www.dermapharm.de |
| Investor Relations URL | N/A |
| HQ State/Province | Bayern (Bavaria) |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | May. 13, 2026 |
| Last Earnings Release | Nov. 13, 2025 |
| Next Ex-Dividend Date | Jun. 30, 2026 |
| Last Ex-Dividend Date | Jun. 27, 2025 |